News | September 28, 2024
Baxter launches nextgen airway clearance system
Developed in consultation with clinicians and patients for an enhanced user experience
Developed in consultation with clinicians and patients for an enhanced user experience
Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotype
The company will also share results in two additional posters for deuruxolitinib
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA
Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma
Tecentriq Hybreza provides patients and physicians with greater flexibility of treatment options while showing safety and efficacy consistent with intravenous
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
This two-day program was attended by 40 doctors & paramedical staff
Subscribe To Our Newsletter & Stay Updated
